Successful treatment of life-threatening ventricular tachycardia with high-dose propranolol under extracorporeal life support and intraaortic balloon pumping.
The use of propranolol is generally contraindicated in patients with congestive heart failure. However, we successfully used a continuous high-dose infusion of propranolol, in combination with the use of extracorporeal life support (ECLS) and intra-aortic balloon pumping (IABP), to treat refractory life-threatening ventricular tachycardia in a patient with postoperative congestive heart failure. The early combined use of ECLS and IABP before irreversible myocardial damage contributed to the successful outcome.
Kurose
M
M
Department of Anesthesiology, Kumamoto University School of Medicine, Japan.
Okamoto
K
K
Sato
T
T
Yatsuda
R
R
Ogata
K
K
Yasumoto
M
M
Terasaki
H
H
Goto
H
H
Okumura
K
K
D003131:Combined Modality Therapy; D005112:Extracorporeal Circulation; D006333:Heart Failure / Q000150:complications / Q000628:therapy; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D008020:Life Support Care; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D017180:Tachycardia, Ventricular / Q000150:complications / Q000188:drug therapy / Q000628:therapy*
D011433:Propranolol